全球輸血診斷市場

預計到 2030 年全球輸血診斷市場規模將達 55 億美元

2024 年全球輸血診斷市場規模估計為 42 億美元，預計到 2030 年將達到 55 億美元，2024-2030 年分析期間的複合年成長率為 4.7%。輸血診斷儀器是報告中分析的細分市場，預計到分析期結束時複合年成長率為 4.4%，達到 17 億美元。在分析期內，輸血診斷試劑套件和試劑部分預計將以 4.9% 的複合年成長率成長。

美國市場預計將達到 11 億美元，中國市場複合年成長率為 7.1%

預計 2024 年美國輸血診斷市場規模將達 11 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 12 億美元，2024-2030 年分析期間的複合年成長率為 7.1%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 2.4% 和 4.4%。在歐洲，德國的複合年成長率預計為 2.8%。

全球輸血診斷市場 - 主要趨勢與促進因素摘要

為什麼輸血診斷在醫療保健中變得越來越重要？

輸血診斷對於確保輸血的安全性和有效性至關重要，每年可以挽救數百萬人的生命。隨著創傷、手術和慢性病的增加，輸血的需求不斷增加，從而推動了對可靠診斷方法的需求，以預防輸血相關併發症。在輸血診斷中，需要進行嚴格的測試以確保血液樣本相容並篩檢愛滋病毒、肝炎和瘧疾等感染疾病。隨著全球對安全輸血的需求不斷增加，特別是在創傷和手術率較高的地區，這些診斷技術已成為世界各地醫療保健系統中不可或缺的一部分。

科技創新如何形塑輸血診斷的未來？

技術創新在推動輸血診斷方面發揮了關鍵作用，提高了準確性和效率。自動化血液篩檢技術正在簡化檢測流程、減少人為錯誤並縮短診斷時間。核酸增幅檢查（NAT）的使用顯著提高了傳染病篩檢的敏感度，可以更早發現血源性病原體。此外，分子診斷和血清學方面的創新正在提高血型和相容性測試的準確性，最大限度地降低輸血相關的風險。人工智慧也擴大被融入輸血診斷中，機器學習演算法提高了識別稀有血型和抗體的預測能力。

輸血診斷市場面臨哪些挑戰？

儘管取得了進步，輸血診斷市場仍面臨著若干挑戰，包括監管障礙、高成本以及對先進基礎設施的需求。關於診斷測試安全性和有效性的法規（尤其是在新興國家）可能非常嚴格，並且可能會減緩新技術的核准和市場開發。此外，實施先進血液篩檢技術的成本對醫院和診所來說可能過高，特別是在資源匱乏的地區。在診斷基礎設施有限的地區，缺乏自動化和熟練的專業人員可能會阻礙現代輸血診斷的採用。然而，隨著這些地區努力加強醫療保健系統並擴大診斷服務範圍，這些障礙正在逐漸減少。

輸血診斷市場的成長受多種因素推動

輸血診斷市場的成長受到多種因素的推動，包括對安全輸血的需求不斷增加、技術創新以及新興市場的需求不斷成長。手術、創傷病例以及癌症和血液疾病治療數量的增加導致對準確血液檢測的需求不斷成長。自動化測試平台和分子診斷等技術進步使得篩檢過程更快、更可靠，進一步推動了市場成長。新興經濟體不斷增加的醫療支出和基礎設施建設為輸血診斷的擴張創造了機會。此外，政府倡導安全輸血實踐的措施和宣傳宣傳活動也有助於市場向前發展。

部分

應用（血型鑑定、疾病篩檢）；最終用途（醫院、血庫、診斷實驗室、血漿分餾公司）；產品類型（儀器、套件、試劑）

受訪公司範例（42家值得關注的公司）

• Abbott Laboratories
• Bag Health Care GmbH
• Bio-Rad Laboratories, Inc.
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Grifols International SA
• Hologic, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics, Inc.
• Quotient Ltd.

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲國家
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Blood Transfusion Diagnostics Market to Reach US$5.5 Billion by 2030

The global market for Blood Transfusion Diagnostics estimated at US$4.2 Billion in the year 2024, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Blood Transfusion Diagnostic Kits & Reagents segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 7.1% CAGR

The Blood Transfusion Diagnostics market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Blood Transfusion Diagnostics Market - Key Trends & Drivers Summarized

Why Is Blood Transfusion Diagnostics Gaining Importance in Healthcare?

Blood transfusion diagnostics are critical to ensuring the safety and effectiveness of blood transfusions, a procedure that saves millions of lives annually. With rising incidences of trauma, surgeries, and chronic diseases, the demand for blood transfusions continues to grow, driving the need for reliable diagnostics to prevent transfusion-related complications. Blood transfusion diagnostics involve rigorous testing of blood samples to ensure compatibility and screen for infectious diseases like HIV, hepatitis, and malaria. As the demand for safe transfusions increases globally, particularly in regions with high rates of trauma and surgery, these diagnostic technologies are becoming essential in healthcare systems worldwide.

How Are Technological Innovations Shaping the Future of Blood Transfusion Diagnostics?

Technological innovations are playing a key role in advancing blood transfusion diagnostics, improving both accuracy and efficiency. Automated blood screening technologies have streamlined the testing process, reducing human error and speeding up diagnosis times. The use of nucleic acid amplification tests (NAT) has significantly improved the sensitivity of infectious disease screening, enabling earlier detection of blood-borne pathogens. Moreover, innovations in molecular diagnostics and serology have enhanced the precision of blood typing and compatibility testing, minimizing the risks associated with transfusions. The integration of AI in transfusion diagnostics is also emerging, with machine learning algorithms enhancing predictive capabilities for identifying rare blood types and antibodies.

What Challenges Does the Blood Transfusion Diagnostics Market Face?

Despite the advancements, the blood transfusion diagnostics market faces several challenges, including regulatory hurdles, high costs, and the need for advanced infrastructure. Strict regulations governing the safety and efficacy of diagnostic tests, particularly in developed countries, can delay the approval and market entry of new technologies. Additionally, the cost of implementing advanced blood screening technologies can be prohibitive for hospitals and clinics, particularly in low-resource settings. In regions with limited access to diagnostic infrastructure, the lack of automation and skilled professionals can hinder the adoption of modern transfusion diagnostics. However, initiatives to strengthen healthcare systems and expand access to diagnostic services in these regions are slowly mitigating these barriers.

The Growth in the Blood Transfusion Diagnostics Market Is Driven by Several Factors

The growth in the blood transfusion diagnostics market is driven by several factors, including the increasing need for safe blood transfusions, technological innovations, and rising demand in emerging markets. The growing number of surgeries, trauma cases, and treatments for conditions such as cancer and blood disorders contribute to the heightened demand for accurate blood testing. Technological advancements, such as automated testing platforms and molecular diagnostics, are making the screening process faster and more reliable, further boosting market growth. Emerging economies are witnessing an increase in healthcare spending and infrastructure development, creating opportunities for the expansion of blood transfusion diagnostics. Furthermore, government initiatives and awareness campaigns promoting safe transfusion practices are also helping to drive the market forward.

SCOPE OF STUDY:

The report analyzes the Blood Transfusion Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Blood Grouping, Disease Screening); End-Use (Hospitals, Blood Banks, Diagnostic Laboratories, Plasma Fractionation Companies); Product Type (Instruments, Kits & Reagents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Bag Health Care GmbH
• Bio-Rad Laboratories, Inc.
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Grifols International SA
• Hologic, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics, Inc.
• Quotient Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Blood Transfusion Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Blood Transfusion Safety and Screening Protocols
  • Increasing Prevalence of Chronic Diseases Requiring Blood Transfusions
  • Adoption of Advanced Blood Typing and Crossmatching Technologies
  • Growth in Blood Donation and Transfusion Rates Globally
  • Technological Innovations in Nucleic Acid Amplification Tests (NAT)
  • Expansion of Blood Screening for Infectious Diseases in Developing Regions
  • Rising Use of Automated Diagnostic Tools for Blood Testing
  • Growing Focus on Safe Transfusion Practices in Healthcare Facilities
  • Increasing Adoption of Molecular Diagnostics for Blood Screening
  • Advancements in Serological Testing for Better Blood Compatibility
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Blood Transfusion Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Blood Transfusion Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Blood Grouping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Blood Grouping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Blood Grouping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Disease Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Disease Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Disease Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Plasma Fractionation Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Plasma Fractionation Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Plasma Fractionation Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• JAPAN
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• CHINA
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• EUROPE
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Blood Transfusion Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• FRANCE
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• GERMANY
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• INDIA
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Blood Transfusion Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Blood Transfusion Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
• AFRICA
  • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030

IV. COMPETITION